Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by Jennifer2020on Dec 02, 2021 3:31pm
149 Views
Post# 34191760

RE:RE:Uplisting underway to OTCQB

RE:RE:Uplisting underway to OTCQBjopatcio, the GE Health Care Edison program is a NON-exclusive agreement so VPT is free to engage as many distributors as they like.
  The official GEHC Edison program launch of VPT technology is expected in Q1 2022 so the DTC with the OTCQB uplisting should come at the perfect time.
   The new board member Fiona Fitzgerald has a wealth of expierence and European contacts, so I am confident we will see new agreements soon as well.
   I don't know for sure if .32 was our bottom, but it is sure looking that way, as I believe the news should flow freely going forward now.
   Don't be fooled by price manipulators and bashers, this is a 1 in 1000 stock.  Rookies should also know you can't claim a tax loss from a registered account like a TFSA and you NEED a capital GAIN to offset to use the tax loss from a regular account.
   I bought more today on the OTCQB news and i hope we stay relatively cheap through Dec so I can add more.  My final thought is the Omicron variant, fingers crossed, so far looks like it is very subtle.  It's highly transmissible but so far many cases have been asymtomatic or only cause mild illness.  It was a good wake up call for people to take Covid seriously and has provided Black Friday prices on VPT.


<< Previous
Bullboard Posts
Next >>